E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/11/2007 in the Prospect News PIPE Daily.

New Issue: Athersys concludes $65 million private placement of stock

By Sheri Kasprzak

New York, June 11 - Athersys, Inc. wrapped a $65 million private placement of shares.

The company sold 13 million shares at $5.00 each to a group of institutional and other investors led by Radius Ventures.

The investors also included OrbiMed Advisors, RA Capital Management, Accipiter Capital Management LLC, Hambrecht & Quist Capital Management LLC, MPM BioEquities and Pappas Ventures.

The investors also received warrants for an undisclosed number of shares each exercisable at $6.00.

Cowen & Co., LLC and National Securities Corp. were the agents for the deal.

The offering was completed as part of Athersys' reverse merger with BTHC VI, Inc. BTHC plans to change its name to Athersys as soon as the requirements are met.

Proceeds will be used for clinical development of the company's lead candidate ATHX-105 to treat obesity, and for its non-embryonic stem cell product, MultiStem to treat cardiovascular disorders, bone marrow transplantation support and other diseases. The rest will be used for preclinical development, debt repayment and working capital and general corporate purposes.

Cleveland-based Athersys is a biotechnology company focused on developing treatments for obesity and other health problems.

Issuer:Athersys, Inc.
Issue:Stock
Amount:$65 million
Shares:13 million
Price:$5.00
Warrants:Undisclosed number
Warrant strike price:$6.00
Investors:Radius Ventures (lead), OrbiMed Advisors, RA Capital Management, Accipiter Capital Management LLC, Hambrecht & Quist Capital Management LLC, MPM BioEquities, Pappas Ventures
Placement agents:Cowen & Co., LLC and National Securities Corp.
Settlement date:June 11

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.